Company / Operating Income
Organogenesis Holdings Inc. Operating Income History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$12.5M
FY2025
5-year range
-$29.9M / $72.2M
FY2021-FY2025
Trend
-43.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income has fluctuated over the past 9 years, ranging from -$52M in FY2020 to $72M in FY2023.
Based on SEC 10-K filings.
$13M in FY2025 with a 3-year CAGR of -22.3%.
Declined from $72M to $13M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -22.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -22.3%, indicating a declining trend.
- In FY2025, operating income decreased 43.8% year-over-year.
- Peak operating income was recorded in FY2023.
- Lowest operating income in the period was in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $12.5M | -43.8% |
| FY2024 | $22.3M | -69.1% |
| FY2023 | $72.2M | +170.5% |
| FY2022 | $26.7M | +189.4% |
| FY2021 | -$29.9M | +42.1% |
| FY2020 | -$51.6M | -838.4% |
| FY2019 | -$5.5M | +37.4% |
| FY2018 | -$8.8M | -4104.6% |
| FY2017 | -$208.7K | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026